Search For "immunotherapy drug"
Cellular messengers improve cancer therapy: Research
Updated : 3 years, 2 months ago IST
Nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumours sensitive to a type of immunotherapy drug called a checkpoint inhibitor. This is according to a new study published in Cancer Immunology Research by researchers at
Read More
Study suggests cancer therapy can be improved by cellular messengers
Updated : 3 years, 2 months ago IST
The findings of a new study suggest that nano-sized membrane bubbles known as extracellular vesicles activate the immune system in mice and seem to render their tumours sensitive to a type of immunotherapy drug called a checkpoint inhibitor.
Read More
Next-generation immunotherapy drug shows promise in some late-stage cancer
Updated : 3 years, 9 months ago IST
Ney York [US], May 27 (ANI): Initial study results prove that an experimental drug called 'nemvaleukin alfa' can be used to treat several types of late-stage cancer in some patients when used alone or in combination with another anticancer drug 'pembrolizumab.'
Read More
Study: Head, neck cancer treatment can be improved by immunotherapy drug
Updated : 4 years ago IST
Ohio [US], March 5 (ANI): By adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features increased, suggests a recently conducted clinical trial by the University of Cincinnati.
Read More
Immunotherapy drug strengthens head, neck cancer treatment: Study
Updated : 4 years ago IST
Ohio [US], March 1 (ANI): A recently conducted clinical trial by the University of Cincinnati showed that by adding an immunotherapy drug to the standard of care treatment regimens, the survival rates for head and neck cancer patients with intermediate-risk features has increased.
Read More
Patients with high-risk local melanomas benefit from immunotherapy drug: S
Updated : 4 years, 5 months ago IST
Pennsylvania [US], September 20 (ANI): According to the results of an international, randomized phase III clinical trial led by UPMC Hillman Cancer Center, immunotherapy called pembrolizumab reduced cancer recurrence after surgery in patients with stage IIb and IIc melanoma.
Read More
Study shows stem-like T cells could aid immunotherapy in cancer treatment
Updated : 4 years, 6 months ago IST
Washington [US], September 3 (ANI): In a new study by Yale Cancer Center, researchers show stem-like T cells within certain lymph nodes could be natural cancer fighters. Targeting these T cells, which are a type of white blood cells, with immunotherapy drugs could increase the number of canc
Read More
New drug combination discovery makes curative surgery possible for liver c
Updated : 4 years, 7 months ago IST
Maryland [US], July 30 (ANI): During a recent study, researchers found that a combination of the immunotherapy drug nivolumab and the kinase-inhibitor drug cabozantinib can make curative surgery possible in some liver cancer patients who would normally not be considered surgical candidates.
Read More
Immunotherapy drugs are riskier for treatment of cancer patients, study su
Updated : 5 years, 3 months ago IST
Washington [US], December 13 (ANI): A study published in the European Heart Journal, found that the risks of heart problems in cancer patients are higher if they are treated with immunotherapy drugs, which can even lead to death from heart attack.
Read More
Study reveals cancer patients receiving immunotherapy drugs have a higher
Updated : 5 years, 3 months ago IST
Washington [US], December 9 (ANI): A study of over a thousand cancer patients treated with immunotherapy drugs has found these patients are at greater risk of heart problems, including death from a heart attack or stroke.
Read More
Study reveals immunotherapy improves survival in advanced bladder cancer p
Updated : 5 years, 5 months ago IST
London [UK], September 18 (ANI): An immunotherapy drug called 'avelumab' has been shown to significantly improve survival in patients with the most common type of bladder cancer, according to results from a phase III clinical trial.
Read More
Study focuses on possible new combination treatment for advanced melanoma
Updated : 6 years, 1 month ago IST
Washington D.C. [USA], Jan 31 (ANI): Researchers discovered that using an immunotherapy drug called NKTR-214, also known as bempegaldesleukin, in combination with an infusion of anti-tumour immune cells, or T cells, may produce a stronger immune response that could help fight advanced melano
Read More